Patent · US Expired

Formulation

US6986904B2 · kind B2 · utility

19Cited by

4References

77Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Hans Nilsson · Lund, SE
Gordon Santesson · Hörby, SE

Key dates

Filing date	Nov 17, 2003
Grant date	Jan 17, 2006
Priority date	—
Expiry date	Nov 17, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A new metered unit dose comprising 40 μg or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.